\"I've tested positive for COVID-19 and would request those who came in contact with me to get themselves tested at the earliest,\" Union minister Smriti Irani said in a tweet

Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively

ICMR in a tweet said, 'scientists at the council have found that the vaccine induces increased memory cell responses and total antibody production in the elderly'

The country's COVID-19 caseload mounted to 79,90,322 with 43,893 fresh cases being reported in a day, while the death toll climbed to 1,20,010 with 508 new fatalities

Passengers can submit their samples at a \"location of choice\", including at home, using the \"At your Doorstep\" service, the airline said, adding that the appointment booking service for testing is being offered by VFS Global

IMS and SUM Hospital is among the 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted

Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective

Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials

Bihar assembly polls: The highlights of the BJP manifesto include the promise of free of cost vaccination for the coronavirus, recruitment of three lakh teachers, five lakh jobs in IT sector and employment in the health sector

Bharat Biotech Phase 3 trials: The volunteers would be given two doses of the experimental vaccine in a gap of 28 days

Flipkart's Big Billion Days sees 55% rise in digital payments, over 150% increase in EMI optionsThe annual festive season sale by Flipkart, The Big Billion Days (TBBD), which concluded on October 21 saw 1.5 times growth in the number of transacting sellers, amongst whom more than 35 per cent saw over thrice the sales compared to last year, said the company in a statement. Even as it added nearly 35 per cent new sellers on its platform, nearly 60 per cent of them were from Tier II and Tier II...

The new COVID testing method implements a highly reliable and accurate molecular diagnostic procedure, conducted in an ultra-low-cost portable device unit, and costs only around Rs 500 per test

Modi insisted on continued social distancing and COVID-appropriate behaviour such as wearing masks, regularly washing hands and sanitation, especially during upcoming festival season

India participated in the trials too. In a statement issued on Friday, ICMR concluded the same and said there were no benefits of remdesivir in any of the patients

Ivermectin, a drug used to treat lice and other parasites, has shown some promising results against coronavirus, claims a specialist from Melbourne

COVID-19 vaccine: Bharat Biotech fast-tracks Covaxin's trials, halves Phase 2 test sizeAs part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half. The vaccine, which Bharat Biotech is developing in collaboration with the country's apex medical research body - Indian Council of Medical Research (ICMR), will now be tested on 380 healthy volunteers in phase 2 a...

Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers

Delhi government on Saturday had ordered shifting of COVID-19 patients from the civic-run hospital to its own facilities

Director General Balram Bhargava said the Indian Council of Medical Research had decided upon a cutoff of 100 days for reinfection if it occurs as, according to some studies, antibodies were also assumed to have a life of four months

\"We're expecting that early next year we should have vaccine in the country from maybe more than one source,\" says union health minister Harsh Vardhan